193 related articles for article (PubMed ID: 25483106)
1. The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer.
Fukumoto K; Taniguchi T; Usami N; Kawaguchi K; Fukui T; Ishiguro F; Nakamura S; Yokoi K
J Epidemiol; 2015; 25(2):110-6. PubMed ID: 25483106
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
[TBL] [Abstract][Full Text] [Related]
3. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
Graziano SL; Tatum AH; Gonchoroff NJ; Newman NB; Kohman LJ
Clin Cancer Res; 1997 Jan; 3(1):87-93. PubMed ID: 9815542
[TBL] [Abstract][Full Text] [Related]
4. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
[TBL] [Abstract][Full Text] [Related]
5. Significance of the serum carcinoembryonic antigen level during the follow-up of patients with completely resected non-small-cell lung cancer.
Ozeki N; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ito S; Sakao Y; Mitsudomi T; Hirakawa A; Yokoi K
Eur J Cardiothorac Surg; 2014 Apr; 45(4):687-92. PubMed ID: 23979987
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
7. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected.
Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Kawamura M
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):14-20. PubMed ID: 25878187
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of preoperative plasma D-dimer level in patients with surgically resected clinical stage I non-small cell lung cancer: a retrospective cohort study.
Kaseda K; Asakura K; Kazama A; Ozawa Y
J Cardiothorac Surg; 2017 Nov; 12(1):102. PubMed ID: 29183325
[TBL] [Abstract][Full Text] [Related]
9. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS
J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer.
Kozu Y; Maniwa T; Takahashi S; Isaka M; Ohde Y; Nakajima T
J Cardiothorac Surg; 2013 Apr; 8():106. PubMed ID: 23607757
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.
Fukai R; Sakao Y; Sakuraba M; Oh S; Shiomi K; Sonobe S; Saitoh Y; Miyamoto H
Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308
[TBL] [Abstract][Full Text] [Related]
13. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
[TBL] [Abstract][Full Text] [Related]
14. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis.
Matsuguma H; Nakahara R; Igarashi S; Ishikawa Y; Suzuki H; Miyazawa N; Honjo S; Yokoi K
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):44-9. PubMed ID: 18179917
[TBL] [Abstract][Full Text] [Related]
15. Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: differences according to histology and smoking status.
Kato T; Ishikawa K; Aragaki M; Sato M; Okamoto K; Ishibashi T; Oba K; Kaji M
J Surg Oncol; 2013 May; 107(6):619-24. PubMed ID: 23192365
[TBL] [Abstract][Full Text] [Related]
16. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of the ABO blood types in Chinese patients with curatively resected non-small cell lung cancer: a retrospective analysis of 1601 cases at a single cancer center.
Li N; Xu M; Li CF; Ou W; Wang BX; Zhang SL; Xu PF; Yuan C; Huang QA; Wang SY
Chin J Cancer; 2015 Sep; 34(10):475-82. PubMed ID: 26411553
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
Higashi K; Ueda Y; Arisaka Y; Sakuma T; Nambu Y; Oguchi M; Seki H; Taki S; Tonami H; Yamamoto I
J Nucl Med; 2002 Jan; 43(1):39-45. PubMed ID: 11801701
[TBL] [Abstract][Full Text] [Related]
19. Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer.
Tomita M; Shimizu T; Ayabe T; Onitsuka T
Asia Pac J Clin Oncol; 2012 Sep; 8(3):244-7. PubMed ID: 22897792
[TBL] [Abstract][Full Text] [Related]
20. Preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer.
Fukumoto K; Taniguchi T; Usami N; Kawaguchi K; Fukui T; Ishiguro F; Nakamura S; Yokoi K
Surg Today; 2015 Jan; 45(1):63-7. PubMed ID: 24781600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
